Replacement therapy in adults, and children and adolescents in:
Primary immunodeficiency syndromes with impaired antibody production
Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed
Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation
Congenital AIDS with recurrent bacterial infectionsImmunomodulation in adults, and children and adolescents in:
Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count
Guillain Barré syndrome.
Kawasaki disease.
Composition: Immunoglobulin normal human 50 mg/ml
Pharmaceutical form: Solution for infusion
Method of administration: intravenous
Manufacturer: Bio Products Laboratory Limited (BPL)
